Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia.
about
The use of US health insurance data for surveillance of rare disorders: hereditary hemorrhagic telangiectasia.Health screening behaviors among adults with hereditary hemorrhagic telangiectasia in North AmericaAccess to personalized medicine: factors influencing the use and value of gene expression profiling in breast cancer treatmentOptimal management of hereditary hemorrhagic telangiectasia.A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective studyPublic awareness of genetic nondiscrimination laws in four states and perceived importance of life insurance protections.Life experiences of individuals with hereditary hemorrhagic telangiectasia and disclosing outside the family: a qualitative analysis.Physicians' perspectives on the uncertainties and implications of chromosomal microarray testing of children and familiesThe future in clinical genetics: affective forecasting biases in patient and clinician decision making.Consumer attitudes towards the establishment of a national Australian familial cancer research database by the Inherited Cancer Connect (ICCon) Partnership.Global trends on fears and concerns of genetic discrimination: a systematic literature review.Personal utility in genomic testing: a systematic literature review.Cost savings through molecular diagnosis for hereditary hemorrhagic telangiectasia.Epistaxis in children and adolescents with hereditary hemorrhagic telangiectasia.
P2860
Q30632145-2C574F28-895F-4216-975D-655D418D6652Q33563773-F0DF0359-F1EA-473A-A801-C945AF0ECF13Q33763903-2A58ED43-5CD4-4F26-A27D-3F7D9904F9D7Q34388065-AC07723A-5725-4291-8577-C3225559ED32Q36281641-2853F43B-FD0A-4ED0-BF9A-C610E668A337Q36433665-AFD40228-15C9-4715-A953-EF78491C937BQ36470912-7F36878D-0863-45BB-BDB4-3C8D382C6D32Q36481170-02C8A5AB-9B12-4A65-9D7C-18705A49D226Q38129456-55121E6C-C239-41F6-BB04-4C2DD8CA6BD2Q38617796-8A3D43DE-BB41-4C66-9FAF-C9FE6080EB0AQ38689049-923814DA-0596-42FF-BA87-422D2BC4E3FCQ38745230-3CCA7455-139A-4176-BEDA-02D92C85CF34Q45130977-FFAB8950-B9A4-48F6-90B4-CC482D9C2500Q46416284-ED690534-967F-4188-B304-A0B0080332E2
P2860
Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Why is genetic screening for a ...... ry hemorrhagic telangiectasia.
@ast
Why is genetic screening for a ...... ry hemorrhagic telangiectasia.
@en
type
label
Why is genetic screening for a ...... ry hemorrhagic telangiectasia.
@ast
Why is genetic screening for a ...... ry hemorrhagic telangiectasia.
@en
prefLabel
Why is genetic screening for a ...... ry hemorrhagic telangiectasia.
@ast
Why is genetic screening for a ...... ry hemorrhagic telangiectasia.
@en
P2860
P1433
P1476
Why is genetic screening for a ...... ry hemorrhagic telangiectasia.
@en
P2093
Cara Zayac
Reed E Pyeritz
P2860
P2888
P304
P356
10.1097/GIM.0B013E31821D2E6D
P407
P577
2011-09-01T00:00:00Z
P6179
1032701070